News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

St. Renatus LLC Planning Phase 3 Trials, Joins SAFE-BioPharma, LLC


9/14/2010 12:01:01 PM

FT. LEE, N.J.--(BUSINESS WIRE)--St. Renatus, LLC, which is dedicated to commercialize the world’s first dental anesthetic administered through the nasal cavity, has joined SAFE-BioPharma Association. SAFE-BioPharma manages the SAFE-BioPharma® digital identity and signature standard, used throughout the biopharmaceutical industry to verify and manage digital identities involved in electronic transactions and to apply digital signatures to electronic documents.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES